2022. Efficacy and Outcomes of Primary Mediastinal B-Cell Lymphoma Patients Treated with DA-EPOCH-R Regimen: A Single-Centre Experience. Sarawak Journal of Pharmacy. 8, 2 (Dec. 2022), 19–30.